In vitro activity of the new quinolone derivative RD-3 against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
Sainath Rao
Shilpakala
S
Department of Genetics, Dr ALMPGIBMS, University of Madras, Taramani Campus, Chennai, India. shilpa_ibms@yahoo.com
Raghunathan
Malathi
M
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D009175:Mycoplasma Infections / Q000382:microbiology*; D019535:Mycoplasma hominis / Q000187:drug effects* / Q000302:isolation & purification; D009177:Mycoplasma pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D015363:Quinolones / Q000737:chemistry / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D015363:Quinolones